Federal contract award
HT942525FE074
COMBINED LONG TERM EFFEROCYTOSIS AND ENHANCED ANTIBODY-DEPENDENT CELL-MEDIATED CYTOTOXICITY RESPONSE HIV VACCINE CLINICAL TRIAL TO INVESTIGATE SAFETY AND IMMUNOGENICITY OF NEW VACCINE CANDIDATES IN SUPPORT OF THE WAR FIGHTER.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | ARMY MED RES ACQ ACTIVITY |
| NAICS | 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| PSC | R405 — Operations Research and Quantitative Analysis Services |
| Parent award / vehicle | W81XWH19D0011 |
| Set-aside | Not reported |
| Pricing type | COST PLUS FIXED FEE |
| Obligations | $1.2M |
| Current contract value | $1.2M |
| Potential contract value / ceiling | $1.2M |
| Start date | Sep 30, 2025 |
| Current end date | Sep 29, 2027 |
| Potential end date | Sep 29, 2027 |
| Latest award activity | Sep 25, 2025 |
| Source loaded | Aug 15, 2026 |
Funding and modification history
Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Sep 25, 2025 | 0 | $1.2M | COMBINED LONG TERM EFFEROCYTOSIS AND ENHANCED ANTIBODY-DEPENDENT CELL-MEDIATED CYTOTOXICITY RESPONSE HIV VACCINE CLINICAL TRIAL TO INVESTIGATE SAFETY AND IMMUNOGENICITY OF NEW VACCINE CANDIDATES IN SUPPORT OF THE WAR FIGHTER. |
Estimated positioning window
Nov 1, 2026 – Mar 29, 2027
55/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 55/100. Available recorded signals: 50 points.
- Contract end 2027-09-29 (332 days from calculation)
- +35 points
- 2 historical awards in this buyer and category group
- +10 points
- 1 recorded award transactions
- +0 points
- Latest award action: 2025-09-25
- +0 points
- Parent award identifier recorded
- +5 points
- Solicitation identifier recorded
- +0 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-11-01 10:17:53.997580+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Nov 1, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.